Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peripheral Nervous System Diseases × Trimetazidine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Peripheral Nervous System Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1

Interventions

Lenalidomide 2 Exercise 2 pembrolizumab 1 nicotinamide-beta-riboside 1 enfortumab vedotin 1 Yoga 1 Vitamin B Complex 1 Trimetazidine 1 Tadalafil 1 Tablets 1 Omeprazole 1 Massage 1 Losartan 1 Gloves, Surgical 1 Fish Oils 1 Fenofibrate 1 Dexamethasone 1 Cryotherapy 1 Corn Oil 1 Control Groups 1 Bortezomib 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06459193 2025-03-30

Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

Minia University

Phase 1/2 Completed

Hereditary Sensory and Autonomic Neuropathies, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡